9 April 2021
The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended that the Pfizer COVID-19 vaccine (Pfizer) is preferred over the AstraZeneca vaccine in adults aged under 50, who face a very slight risk of blood clots with the latter dosage.
However, if you have had your first AstraZeneca vaccine dose without this side effect or other serious adverse effects, the advice is you should receive your second dose as planned.
The ANMF (SA Branch) is seeking information to ensure the availability of the Pfizer vaccine to frontline workers who are at increased risk under this latest advice. We recently wrote to Health Minister Stephen Wade seeking clarification on the Pfizer vaccine (read the letter
) but are yet to receive a reply.
ATAGI has recommended the AstraZeneca vaccine remains safe to be given to people aged 50 years and over.
What if I am worried about side effects?
If you have recently had your first AstraZeneca vaccine dose and are experiencing any side effects that you are worried about, you should consult your doctor.
I’m booked in for my first dose of the AstraZeneca COVID-19 vaccine, what do I do?
If you are an adult aged under 50 years, you should only receive a first dose of AstraZeneca COVID-19 vaccine where the benefit of receiving the vaccine clearly outweighs the risk in your individual circumstance. You may wish to discuss your individual benefit-to-risk balance with your doctor.
Generally, if you have not already received a first dose of the AstraZeneca COVID-19 vaccine, then the Pfizer COVID-19 vaccine is preferred in adults aged under 50 years.
Information about how to receive the Pfizer COVID-19 vaccine will be available on the Department of Health website shortly.
If you are 50 years of age or older, you can still receive your AstraZeneca COVID-19 vaccine.